Sustainability & Climate

Cobra Electronics is challenging the professional radio market with a new digital series for SMBs, aiming to make high-end communication accessible and simple.

InstallatørGruppen's strong Nasdaq debut was a win for the green transition, but a price dip and a quick correction reveal the complex realities of going public.

A complex deal hands voting control of refrigeration giant Beijer Ref to a new industrial owner, marking a strategic pivot from EQT's PE-led era.

Hyundai Bioscience offers a free drug for an untreatable Ebola strain. It's a bold humanitarian gesture, and a masterclass in strategic maneuvering.

After nearly half a century, Yakult Singapore's new peach flavor is more than a product update. It's a calculated move in a high-stakes 'cultured war'.

The maker of Crisco and Cream of Wheat extends its debt maturity to 2031, but at a staggering 11% rate, revealing the harsh realities of today's credit markets.

Athletes are ditching complex supplement stacks for all-in-one EAA formulas. We explore the science and the industry shift fueling this minimalist movement.

Aethlon Medical is advancing a device to filter pathogens from the bloodstream, viewing it as a firewall for the body's internal communication network.

The global aerostructures market is set to soar to $142.7B, but this growth hinges on a high-stakes race of innovation against rising costs and talent gaps.

As farmers face a historic squeeze, Leaf Agriculture's new funding aims to build the data plumbing for an AI revolution, turning data chaos into profit.

A major financial outlook warns that geopolitical fragmentation, stubborn inflation, and a new AI arms race are creating a new reality for investors.

A new poll shows crypto voters have doubled, but the real story is a deeper anxiety over data privacy that is creating a powerful new political force.

MRI Software’s recent Digie Award for its AI platform, Agora, isn't just a win; it's a marker for the tech-driven restructuring of commercial real estate.

Organon's FDA nod for TOFIDENCE in critical care isn't just a clinical win. It's a calculated move to capture market share and challenge high-cost biologics.

A new 225-residence community breaks ground in Issaquah, aiming to address the Eastside's senior housing shortage with an integrated healthcare model.

Leading Edge Materials confirms a low-cost, high-purity graphite process at its Swedish mine, positioning Woxna to supply Europe's booming EV battery market.

A landmark deal locks in energy for Ukraine and Finland until 2044, cementing a small Baltic terminal as a powerhouse of European strategic resilience.

Pollo AI's new Commerce Studio promises to slash product visual costs for sellers. But as AI automates the photo shoot, it raises critical questions about creative jobs and consumer trust.

ERock hits the NYSE, selling investors on a solution to the AI energy crisis. But with steep losses and regulatory hurdles, its future is far from guaranteed.

Takeda seeks FDA approval for its gut-focused drug ENTYVIO in children, a major step toward a new era of treatment for the rising tide of pediatric IBD.